1: Roche MI, Griesemer I, Khan CM, Moore E, Lin FC, O’Daniel JM, Foreman AKM, Lee
\nK, Powell BC, Berg JS, Evans JP, Henderson GE, Rini C. Factors influencing
\nNCGENES research participants’ requests for non-medically actionable secondary
\nfindings. Genet Med. 2018 Sep 21. doi: 10.1038\/s41436-018-0294-z. [Epub ahead of
\nprint] PubMed PMID: 30237575.<\/p>\n
2: Moore EG, Roche M, Rini C, Corty EW, Girnary Z, O’Daniel JM, Lin FC,
\nCorbie-Smith G, Evans JP, Henderson GE, Berg JS. Examining the Cascade of
\nParticipant Attrition in a Genomic Medicine Research Study: Barriers and
\nFacilitators to Achieving Diversity. Public Health Genomics. 2017;20(6):332-342.
\ndoi: 10.1159\/000490519. Epub 2018 Aug 7. PubMed PMID: 30086550; PubMed Central
\nPMCID: PMC6112240.<\/p>\n
3: Butterfield RM, Evans JP, Rini C, Kuczynski KJ, Waltz M, Cadigan RJ, Goddard
\nKAB, Muessig KR, Henderson GE. Returning negative results to individuals in a
\ngenomic screening program: lessons learned. Genet Med. 2018 Jun 6. doi:
\n10.1038\/s41436-018-0061-1. [Epub ahead of print] PubMed PMID: 29875426.<\/p>\n
4: Meagher KM, Juengst ET, Henderson GE. Grudging Trust and the Limits of
\nTrustworthy Biorepository Curation. Am J Bioeth. 2018 Apr;18(4):23-25. doi:
\n10.1080\/15265161.2018.1431329. PubMed PMID: 29621446; PubMed Central PMCID:
\nPMC6192541.<\/p>\n
5: Skinner D, Roche MI, Weck KE, Raspberry KA, Foreman AKM, Strande NT, Berg JS,
\nEvans JP, Henderson GE. “Possibly positive or certainly uncertain?”:
\nparticipants’ responses to uncertain diagnostic results from exome sequencing.
\nGenet Med. 2018 Mar;20(3):313-319. doi: 10.1038\/gim.2017.135. Epub 2017 Oct 2.
\nPubMed PMID: 29593351; PubMed Central PMCID: PMC5880300.<\/p>\n
6: Rini C, Khan CM, Moore E, Roche MI, Evans JP, Berg JS, Powell BC, Corbie-Smith
\nG, Foreman AKM, Griesemer I, Lee K, O’Daniel JM, Henderson GE. The who, what, and
\nwhy of research participants’ intentions to request a broad range of secondary
\nfindings in a diagnostic genomic sequencing study. Genet Med. 2018
\nJul;20(7):760-769. doi: 10.1038\/gim.2017.176. Epub 2017 Oct 26. PubMed PMID:
\n29261173; PubMed Central PMCID: PMC5920790.<\/p>\n
7: Waltz M, Cadigan RJ, Prince AER, Skinner D, Henderson GE. Age and perceived
\nrisks and benefits of preventive genomic screening. Genet Med. 2018
\nSep;20(9):1038-1044. doi: 10.1038\/gim.2017.206. Epub 2017 Dec 7. PubMed PMID:
\n29215654; PubMed Central PMCID: PMC5991986.<\/p>\n
8: Cadigan RJ, Butterfield R, Rini C, Waltz M, Kuczynski KJ, Muessig K, Goddard
\nKAB, Henderson GE. Online Education and e-Consent for GeneScreen, a Preventive
\nGenomic Screening Study. Public Health Genomics. 2017;20(4):235-246. doi:
\n10.1159\/000481359. Epub 2017 Oct 26. PubMed PMID: 29069655; PubMed Central PMCID:
\nPMC5698149.<\/p>\n
9: Wolf SM, Amendola LM, Berg JS, Chung WK, Clayton EW, Green RC, Harris-Wai J,
\nHenderson GE, Jarvik GP, Koenig BA, Lehmann LS, McGuire AL, O’Rourke P, Somkin C,
\nWilfond BS, Burke W. Navigating the research-clinical interface in genomic
\nmedicine: analysis from the CSER Consortium. Genet Med. 2018 Apr;20(5):545-553.
\ndoi: 10.1038\/gim.2017.137. Epub 2017 Aug 31. PubMed PMID: 28858330; PubMed
\nCentral PMCID: PMC5832495.<\/p>\n
10: Prince AE, Cadigan RJ, Henderson GE, Evans JP, Adams M, Coker-Schwimmer E,
\nPenn DC, Van Riper M, Corbie-Smith G, Jonas DE. Is there evidence that we should
\nscreen the general population for Lynch syndrome with genetic testing? A
\nsystematic review. Pharmgenomics Pers Med. 2017 Feb 20;10:49-60. doi:
\n10.2147\/PGPM.S123808. eCollection 2017. Review. PubMed PMID: 28260941; PubMed
\nCentral PMCID: PMC5325104.<\/p>\n
11: Cadigan RJ, Edwards TP, Lassiter D, Davis AM, Henderson GE.
\n“Forward-Thinking” in U.S. Biobanking. Genet Test Mol Biomarkers. 2017
\nMar;21(3):148-154. doi: 10.1089\/gtmb.2016.0393. Epub 2017 Jan 24. PubMed PMID:
\n28118036; PubMed Central PMCID: PMC5367905.<\/p>\n
12: Cohn EG, Henderson GE, Appelbaum PS. Distributive justice, diversity, and
\ninclusion in precision medicine: what will success look like? Genet Med. 2017
\nFeb;19(2):157-159. doi: 10.1038\/gim.2016.92. Epub 2016 Aug 4. Erratum in: Genet
\nMed. 2016 Nov;18(11):1166. PubMed PMID: 27490116; PubMed Central PMCID:
\nPMC5291806.<\/p>\n
13: Tan N, Amendola LM, O’Daniel JM, Burt A, Horike-Pyne MJ, Boshe L, Henderson
\nGE, Rini C, Roche MI, Hisama FM, Burke W, Wilfond B, Jarvik GP. Is “incidental
\nfinding” the best term?: a study of patients’ preferences. Genet Med. 2017
\nFeb;19(2):176-181. doi: 10.1038\/gim.2016.96. Epub 2016 Aug 4. PubMed PMID:
\n27490114; PubMed Central PMCID: PMC5291803.<\/p>\n
14: Green RC, Goddard KA, Jarvik GP, Amendola LM, Appelbaum PS, Berg JS,
\nBernhardt BA, Biesecker LG, Biswas S, Blout CL, Bowling KM, Brothers KB, Burke W,
\nCaga-Anan CF, Chinnaiyan AM, Chung WK, Clayton EW, Cooper GM, East K, Evans JP,
\nFullerton SM, Garraway LA, Garrett JR, Gray SW, Henderson GE, Hindorff LA, Holm
\nIA, Lewis MH, Hutter CM, Janne PA, Joffe S, Kaufman D, Knoppers BM, Koenig BA,
\nKrantz ID, Manolio TA, McCullough L, McEwen J, McGuire A, Muzny D, Myers RM,
\nNickerson DA, Ou J, Parsons DW, Petersen GM, Plon SE, Rehm HL, Roberts JS,
\nRobinson D, Salama JS, Scollon S, Sharp RR, Shirts B, Spinner NB, Tabor HK,
\nTarczy-Hornoch P, Veenstra DL, Wagle N, Weck K, Wilfond BS, Wilhelmsen K, Wolf
\nSM, Wynn J, Yu JH; CSER Consortium. Clinical Sequencing Exploratory Research
\nConsortium: Accelerating Evidence-Based Practice of Genomic Medicine. Am J Hum
\nGenet. 2016 Jul 7;99(1):246. doi: 10.1016\/j.ajhg.2016.06.002. PubMed PMID:
\n27392080; PubMed Central PMCID: PMC5005464.<\/p>\n
15: Adams MC, Evans JP, Henderson GE, Berg JS. The promise and peril of genomic
\nscreening in the general population. Genet Med. 2016 Jun;18(6):593-9. doi:
\n10.1038\/gim.2015.136. Epub 2015 Nov 5. PubMed PMID: 26540154; PubMed Central
\nPMCID: PMC4860183.<\/p>\n
16: Cadigan RJ, Nelson DK, Henderson GE, Nelson AG, Davis AM. Public Comments on
\nProposed Regulatory Reforms That Would Impact Biospecimen Research: The Good, the
\nBad, and the Puzzling. IRB. 2015 Sep-Oct;37(5):1-10. PubMed PMID: 26523321.<\/p>\n
17: Henderson GE. With great (participant) rights comes great (researcher)
\nresponsibility. Genet Med. 2016 Feb;18(2):124-5. doi: 10.1038\/gim.2015.67. Epub
\n2015 May 7. PubMed PMID: 25950735.<\/p>\n
18: Khan CM, Rini C, Bernhardt BA, Roberts JS, Christensen KD, Evans JP, Brothers
\nKB, Roche MI, Berg JS, Henderson GE. Erratum to: How can psychological science
\ninform research about genetic counseling for clinical genomic sequencing? J Genet
\nCouns. 2015 Apr;24(2):372. doi: 10.1007\/s10897-014-9814-4. PubMed PMID: 25539761.<\/p>\n
19: Khan CM, Rini C, Bernhardt BA, Roberts JS, Christensen KD, Evans JP, Brothers
\nKB, Roche MI, Berg JS, Henderson GE. How can psychological science inform
\nresearch about genetic counseling for clinical genomic sequencing? J Genet Couns.
\n2015 Apr;24(2):193-204. doi: 10.1007\/s10897-014-9804-6. Epub 2014 Dec 9. Erratum
\nin: J Genet Couns. 2015 Apr;24(2):372. PubMed PMID: 25488723; PubMed Central
\nPMCID: PMC4777349.<\/p>\n
20: Cadigan RJ, Lassiter D, Haldeman K, Conlon I, Reavely E, Henderson GE.
\nNeglected ethical issues in biobank management: Results from a U.S. study. Life
\nSci Soc Policy. 2013 Dec 1;9(1):1. PubMed PMID: 25401081; PubMed Central PMCID:
\nPMC4228790.<\/p>\n
21: Henderson GE, Wolf SM, Kuczynski KJ, Joffe S, Sharp RR, Parsons DW, Knoppers
\nBM, Yu JH, Appelbaum PS. The challenge of informed consent and return of results
\nin translational genomics: empirical analysis and recommendations. J Law Med
\nEthics. 2014 Fall;42(3):344-55. doi: 10.1111\/jlme.12151. PubMed PMID: 25264092;
\nPubMed Central PMCID: PMC4262925.<\/p>\n
22: Edwards T, Cadigan RJ, Evans JP, Henderson GE. Biobanks containing clinical
\nspecimens: defining characteristics, policies, and practices. Clin Biochem. 2014
\nMar;47(4-5):245-51. doi: 10.1016\/j.clinbiochem.2013.11.023. Epub 2013 Dec 15.
\nPubMed PMID: 24345347; PubMed Central PMCID: PMC3959281.<\/p>\n
23: Henderson GE, Edwards TP, Cadigan RJ, Davis AM, Zimmer C, Conlon I, Weiner
\nBJ. Stewardship practices of U.S. biobanks. Sci Transl Med. 2013 Dec
\n11;5(215):215cm7. doi: 10.1126\/scitranslmed.3007362. PubMed PMID: 24337477;
\nPubMed Central PMCID: PMC4185188.<\/p>\n
24: Burke W, Antommaria AH, Bennett R, Botkin J, Clayton EW, Henderson GE, Holm
\nIA, Jarvik GP, Khoury MJ, Knoppers BM, Press NA, Ross LF, Rothstein MA, Saal H,
\nUhlmann WR, Wilfond B, Wolf SM, Zimmern R. Recommendations for returning genomic
\nincidental findings? We need to talk! Genet Med. 2013 Nov;15(11):854-9. doi:
\n10.1038\/gim.2013.113. Epub 2013 Aug 1. Review. PubMed PMID: 23907645; PubMed
\nCentral PMCID: PMC3832423.<\/p>\n
25: Henderson GE, Cadigan RJ, Edwards TP, Conlon I, Nelson AG, Evans JP, Davis
\nAM, Zimmer C, Weiner BJ. Characterizing biobank organizations in the U.S.:
\nresults from a national survey. Genome Med. 2013 Jan 25;5(1):3. doi:
\n10.1186\/gm407. eCollection 2013. PubMed PMID: 23351549; PubMed Central PMCID:
\nPMC3706795.<\/p>\n
26: Henderson GE, Juengst ET, King NM, Kuczynski K, Michie M. What research
\nethics should learn from genomics and society research: lessons from the ELSI
\nCongress of 2011. J Law Med Ethics. 2012 Winter;40(4):1008-24. doi:
\n10.1111\/j.1748-720X.2012.00728.x. PubMed PMID: 23289702; PubMed Central PMCID:
\nPMC4103651.<\/p>\n
27: Churchill LR, King NM, Henderson GE. Why we should continue to worry about
\nthe therapeutic misconception. J Clin Ethics. 2013 Winter;24(4):381-6. PubMed
\nPMID: 24597426.<\/p>\n
28: Boyer GJ, Whipple W, Cadigan RJ, Henderson GE. Biobanks in the United States:
\nhow to identify an undefined and rapidly evolving population. Biopreserv Biobank.
\n2012 Dec;10(6):511-7. doi: 10.1089\/bio.2012.0034. PubMed PMID: 24845137; PubMed
\nCentral PMCID: PMC4076972.<\/p>\n
29: Beskow LM, Namey EE, Cadigan RJ, Brazg T, Crouch J, Henderson GE, Michie M,
\nNelson DK, Tabor HK, Wilfond BS. Research participants’ perspectives on
\ngenotype-driven research recruitment. J Empir Res Hum Res Ethics. 2011
\nDec;6(4):3-20. doi: 10.1525\/jer.2011.6.4.3. PubMed PMID: 22228056; PubMed Central
\nPMCID: PMC3395316.<\/p>\n
30: Henderson GE. Is informed consent broken? Am J Med Sci. 2011
\nOct;342(4):267-72. doi: 10.1097\/MAJ.0b013e31822a6c47. Review. PubMed PMID:
\n21817873.<\/p>\n
31: Henderson GE, Churchill LR, Davis AM, Easter MM, Grady C, Joffe S, Kass N,
\nKing NM, Lidz CW, Miller FG, Nelson DK, Peppercorn J, Rothschild BB, Sankar P,
\nWilfond BS, Zimmer CR. Clinical trials and medical care: defining the therapeutic
\nmisconception. PLoS Med. 2007 Nov 27;4(11):e324. PubMed PMID: 18044980; PubMed
\nCentral PMCID: PMC2082641.<\/p>\n
32: Rivera SM, Brothers KB, Cadigan RJ, Harrell HL, Rothstein MA, Sharp RR,
\nGoldenberg AJ. Modernizing Research Regulations Is Not Enough: It’s Time to Think
\nOutside the Regulatory Box. Am J Bioeth. 2017 Jul;17(7):1-3. doi:
\n10.1080\/15265161.2017.1328899. PubMed PMID: 28661748; PubMed Central PMCID:
\nPMC6089353.<\/p>\n
33: L\u00e1zaro-Mu\u00f1oz G, Conley JM, Davis AM, Prince AE, Cadigan RJ. Which Results to
\nReturn: Subjective Judgments in Selecting Medically Actionable Genes. Genet Test
\nMol Biomarkers. 2017 Mar;21(3):184-194. doi: 10.1089\/gtmb.2016.0397. Epub 2017
\nFeb 1. PubMed PMID: 28146641; PubMed Central PMCID: PMC5367906.<\/p>\n
34: Prince AE, Conley JM, Davis AM, L\u00e1zaro-Mu\u00f1oz G, Cadigan RJ. Automatic
\nPlacement of Genomic Research Results in Medical Records: Do Researchers Have a
\nDuty? Should Participants Have a Choice? J Law Med Ethics. 2015
\nWinter;43(4):827-42. doi: 10.1111\/jlme.12323. PubMed PMID: 26711421; PubMed
\nCentral PMCID: PMC4780406.<\/p>\n
35: Conley JM, L\u00e1zaro-Mu\u00f1oz G, Prince AE, Davis AM, Cadigan RJ. Scientific Social
\nResponsibility: Lessons From the Corporate Social Responsibility Movement. Am J
\nBioeth. 2015;15(12):64-6. doi: 10.1080\/15265161.2015.1103812. PubMed PMID:
\n26632370; PubMed Central PMCID: PMC4751582.<\/p>\n
36: Long MD, Cadigan RJ, Cook SF, Haldeman K, Kuczynski K, Sandler RS, Martin CF,
\nChen W, Kappelman MD. Perceptions of patients with inflammatory bowel diseases on
\nbiobanking. Inflamm Bowel Dis. 2015 Jan;21(1):132-8. doi:
\n10.1097\/MIB.0000000000000263. PubMed PMID: 25489961; PubMed Central PMCID:
\nPMC4573563.<\/p>\n
37: Isler MR, Sutton K, Cadigan RJ, Corbie-Smith G. Community perceptions of
\ngenomic research: implications for addressing health disparities. N C Med J. 2013
\nNov-Dec;74(6):470-6. PubMed PMID: 24316767.<\/p>\n
38: Conley JM, Mitchell R, Cadigan RJ, Davis AM, Dobson AW, Gladden RQ. A trade
\nsecret model for genomic biobanking. J Law Med Ethics. 2012 Fall;40(3):612-29.
\ndoi: 10.1111\/j.1748-720X.2012.00694.x. PubMed PMID: 23061589; PubMed Central
\nPMCID: PMC3476050.<\/p>\n
39: Michie M, Cadigan RJ, Henderson G, Beskow LM. Am I a control?:
\nGenotype-driven research recruitment and self-understandings of study
\nparticipants. Genet Med. 2012 Dec;14(12):983-9. doi: 10.1038\/gim.2012.88. Epub
\n2012 Aug 30. PubMed PMID: 22935717; PubMed Central PMCID: PMC3578310.<\/p>\n
40: Cadigan RJ, Michie M, Henderson G, Davis AM, Beskow LM. The meaning of
\ngenetic research results: reflections from individuals with and without a known
\ngenetic disorder. J Empir Res Hum Res Ethics. 2011 Dec;6(4):30-40. doi:
\n10.1525\/jer.2011.6.4.30. PubMed PMID: 22228058; PubMed Central PMCID: PMC3386306.<\/p>\n
41: Mitchell R, Conley JM, Davis AM, Cadigan RJ, Dobson AW, Gladden RQ. Genomics.
\nGenomics, biobanks, and the trade-secret model. Science. 2011 Apr
\n15;332(6027):309-10. doi: 10.1126\/science.1199554. PubMed PMID: 21493846.<\/p>\n
42: Juengst ET, McGowan ML. Why Does the Shift from “Personalized Medicine” to
\n“Precision Health” and “Wellness Genomics” Matter? AMA J Ethics. 2018 Sep
\n1;20(9):E881-890. doi: 10.1001\/amajethics.2018.881. PubMed PMID: 30242820.<\/p>\n
43: Johnston J, Juengst E. Are Parents Really Obligated to Learn as Much as
\nPossible about Their Children’s Genomes? Hastings Cent Rep. 2018 Jul;48 Suppl
\n2:S14-S15. doi: 10.1002\/hast.877. PubMed PMID: 30133729.<\/p>\n
44: Kaye J, Terry SF, Juengst E, Coy S, Harris JR, Chalmers D, Dove ES,
\nBudin-Lj\u00f8sne I, Adebamowo C, Ogbe E, Bezuidenhout L, Morrison M, Minion JT,
\nMurtagh MJ, Minari J, Teare H, Isasi R, Kato K, Rial-Sebbag E, Marshall P, Koenig
\nB, Cambon-Thomsen A. Including all voices in international data-sharing
\ngovernance. Hum Genomics. 2018 Mar 7;12(1):13. doi: 10.1186\/s40246-018-0143-9.
\nPubMed PMID: 29514717; PubMed Central PMCID: PMC5842530.<\/p>\n
45: Juengst ET. Crowdsourcing the Moral Limits of Human Gene Editing? Hastings
\nCent Rep. 2017 May;47(3):15-23. doi: 10.1002\/hast.701. PubMed PMID: 28543411.<\/p>\n
46: Meagher KM, McGowan ML, Settersten RA Jr, Fishman JR, Juengst ET. Precisely
\nWhere Are We Going? Charting the New Terrain of Precision Prevention. Annu Rev
\nGenomics Hum Genet. 2017 Aug 31;18:369-387. doi:
\n10.1146\/annurev-genom-091416-035222. Epub 2017 Apr 24. Review. PubMed PMID:
\n28441061; PubMed Central PMCID: PMC6203331.<\/p>\n
47: Juengst E, McGowan ML, Fishman JR, Settersten RA Jr. From “Personalized” to
\n“Precision” Medicine: The Ethical and Social Implications of Rhetorical Reform in
\nGenomic Medicine. Hastings Cent Rep. 2016 Sep;46(5):21-33. doi: 10.1002\/hast.614.
\nPubMed PMID: 27649826; PubMed Central PMCID: PMC5153661.<\/p>\n
48: Woolley JP, McGowan ML, Teare HJ, Coathup V, Fishman JR, Settersten RA Jr,
\nSterckx S, Kaye J, Juengst ET. Citizen science or scientific citizenship?
\nDisentangling the uses of public engagement rhetoric in national research
\ninitiatives. BMC Med Ethics. 2016 Jun 4;17(1):33. doi: 10.1186\/s12910-016-0117-1.
\nPubMed PMID: 27260081; PubMed Central PMCID: PMC4893207.<\/p>\n
49: L\u00e1zaro-Mu\u00f1oz G, Conley JM, Davis AM, Van Riper M, Walker RL, Juengst ET.
\nResponse to Open Peer Commentaries on “Looking for Trouble: Preventive Genomic
\nSequencing in the General Population and the Role of Patient Choice”. Am J
\nBioeth. 2015;15(12):W6-9. doi: 10.1080\/15265161.2015.1096069. PubMed PMID:
\n26632375.<\/p>\n
50: L\u00e1zaro-Mu\u00f1oz G, Juengst ET. CHALLENGES FOR IMPLEMENTING A PTSD PREVENTIVE
\nGENOMIC SEQUENCING PROGRAM IN THE U.S. MILITARY. Case West Reserve J Int Law.
\n2015 Spring;47(1):87-113. PubMed PMID: 26401056; PubMed Central PMCID:
\nPMC4577019.<\/p>\n
51: Berg JS, Foreman AK, O’Daniel JM, Booker JK, Boshe L, Carey T, Crooks KR,
\nJensen BC, Juengst ET, Lee K, Nelson DK, Powell BC, Powell CM, Roche MI, Skrzynia
\nC, Strande NT, Weck KE, Wilhelmsen KC, Evans JP. A semiquantitative metric for
\nevaluating clinical actionability of incidental or secondary findings from
\ngenome-scale sequencing. Genet Med. 2016 May;18(5):467-75. doi:
\n10.1038\/gim.2015.104. Epub 2015 Aug 13. PubMed PMID: 26270767; PubMed Central
\nPMCID: PMC4752935.<\/p>\n
52: L\u00e1zaro-Mu\u00f1oz G, Conley JM, Davis AM, Van Riper M, Walker RL, Juengst ET.
\nLooking for Trouble: Preventive Genomic Sequencing in the General Population and
\nthe Role of Patient Choice. Am J Bioeth. 2015;15(7):3-14. doi:
\n10.1080\/15265161.2015.1039721. PubMed PMID: 26147254; PubMed Central PMCID:
\nPMC4493927.<\/p>\n
53: McGowan ML, Fishman JR, Settersten RA Jr, Lambrix MA, Juengst ET. Gatekeepers
\nor intermediaries? The role of clinicians in commercial genomic testing. PLoS
\nOne. 2014 Sep 26;9(9):e108484. doi: 10.1371\/journal.pone.0108484. eCollection
\n2014. PubMed PMID: 25259512; PubMed Central PMCID: PMC4178171.<\/p>\n
54: Juengst ET, Fishman JR, McGowan ML, Settersten RA Jr. Serving epigenetics
\nbefore its time. Trends Genet. 2014 Oct;30(10):427-9. doi:
\n10.1016\/j.tig.2014.08.001. PubMed PMID: 25242336.<\/p>\n
55: Walker RL, Juengst ET, Whipple W, Davis AM. Genomic research with the newly
\ndead: a crossroads for ethics and policy. J Law Med Ethics. 2014
\nSummer;42(2):220-31. doi: 10.1111\/jlme.12137. PubMed PMID: 25040385; PubMed
\nCentral PMCID: PMC4378691.<\/p>\n
56: Burke W, Appelbaum P, Dame L, Marshall P, Press N, Pyeritz R, Sharp R,
\nJuengst E. The translational potential of research on the ethical, legal, and
\nsocial implications of genomics. Genet Med. 2015 Jan;17(1):12-20. doi:
\n10.1038\/gim.2014.74. Epub 2014 Jun 19. Review. PubMed PMID: 24946153; PubMed
\nCentral PMCID: PMC4272334.<\/p>\n
57: Choudhury S, Fishman JR, McGowan ML, Juengst ET. Big data, open science and
\nthe brain: lessons learned from genomics. Front Hum Neurosci. 2014 May 16;8:239.
\ndoi: 10.3389\/fnhum.2014.00239. eCollection 2014. Review. PubMed PMID: 24904347;
\nPubMed Central PMCID: PMC4032989.<\/p>\n
58: Juengst ET. TMI! ethical challenges in managing and using large patient data
\nsets. N C Med J. 2014 May-Jun;75(3):214-7. PubMed PMID: 24830499.<\/p>\n
59: McGowan ML, Settersten RA Jr, Juengst ET, Fishman JR. Integrating genomics
\ninto clinical oncology: ethical and social challenges from proponents of
\npersonalized medicine. Urol Oncol. 2014 Feb;32(2):187-92. doi:
\n10.1016\/j.urolonc.2013.10.009. PubMed PMID: 24445286; PubMed Central PMCID:
\nPMC3900115.<\/p>\n
60: Holm IA, Savage SK, Green RC, Juengst E, McGuire A, Kornetsky S, Brewster SJ,
\nJoffe S, Taylor P. Guidelines for return of research results from pediatric
\ngenomic studies: deliberations of the Boston Children’s Hospital Gene Partnership
\nInformed Cohort Oversight Board. Genet Med. 2014 Jul;16(7):547-52. doi:
\n10.1038\/gim.2013.190. Epub 2014 Jan 9. PubMed PMID: 24406460.<\/p>\n
61: Juengst ET, Settersten RA Jr, Fishman JR, McGowan ML. After the revolution?
\nEthical and social challenges in ‘personalized genomic medicine’. Per Med. 2012
\nJun 1;9(4):429-439. PubMed PMID: 23662108; PubMed Central PMCID: PMC3646379.<\/p>\n
62: Juengst ET, Flatt MA, Settersten RA Jr. Personalized genomic medicine and the
\nrhetoric of empowerment. Hastings Cent Rep. 2012 Sep-Oct;42(5):34-40. doi:
\n10.1002\/hast.65. PubMed PMID: 22976411; PubMed Central PMCID: PMC3641662.<\/p>\n
63: Kaye J, Meslin EM, Knoppers BM, Juengst ET, Desch\u00eanes M, Cambon-Thomsen A,
\nChalmers D, De Vries J, Edwards K, Hoppe N, Kent A, Adebamowo C, Marshall P, Kato
\nK. Research priorities. ELSI 2.0 for genomics and society. Science. 2012 May
\n11;336(6082):673-4. doi: 10.1126\/science.1218015. PubMed PMID: 22582247; PubMed
\nCentral PMCID: PMC4151290.<\/p>\n
64: Dressler LG, Smolek S, Ponsaran R, Markey JM, Starks H, Gerson N, Lewis S,
\nPress N, Juengst E, Wiesner GL; GRRIP Consortium. IRB perspectives on the return
\nof individual results from genomic research. Genet Med. 2012 Feb;14(2):215-22.
\ndoi: 10.1038\/gim.2011.10. Epub 2012 Jan 5. PubMed PMID: 22241094; PubMed Central
\nPMCID: PMC3493147.<\/p>\n
65: Mehlman MJ, Berg JW, Juengst ET, Kodish E. Ethical and legal issues in
\nenhancement research on human subjects. Camb Q Healthc Ethics. 2011
\nJan;20(1):30-45. doi: 10.1017\/S0963180110000605. PubMed PMID: 21223608.<\/p>\n
66: Coors ME, Glover JJ, Juengst ET, Sikela JM. The ethics of using transgenic
\nnon-human primates to study what makes us human. Nat Rev Genet. 2010
\nSep;11(9):658-62. doi: 10.1038\/nrg2864. Review. PubMed PMID: 20717156; PubMed
\nCentral PMCID: PMC2995325.<\/p>\n
67: Callier SL, Huss J, Juengst ET. GINA and preemployment criminal background
\nchecks. Hastings Cent Rep. 2010 Jan-Feb;40(1):15-9. PubMed PMID: 20169652; PubMed
\nCentral PMCID: PMC3380532.<\/p>\n
68: Gaines AD, Juengst ET. Origin myths in Bioethics: constructing sources,
\nmotives and reason in Bioethic(s). Cult Med Psychiatry. 2008 Sep;32(3):303-27.
\ndoi: 10.1007\/s11013-008-9105-3. PubMed PMID: 18574678.<\/p>\n
69: Caulfield T, McGuire AL, Cho M, Buchanan JA, Burgess MM, Danilczyk U, Diaz
\nCM, Fryer-Edwards K, Green SK, Hodosh MA, Juengst ET, Kaye J, Kedes L, Knoppers
\nBM, Lemmens T, Meslin EM, Murphy J, Nussbaum RL, Otlowski M, Pullman D, Ray PN,
\nSugarman J, Timmons M. Research ethics recommendations for whole-genome research:
\nconsensus statement. PLoS Biol. 2008 Mar 25;6(3):e73. doi:
\n10.1371\/journal.pbio.0060073. PubMed PMID: 18366258; PubMed Central PMCID:
\nPMC2270329.<\/p>\n
70: Beskow LM, Fullerton SM, Namey EE, Nelson DK, Davis AM, Wilfond BS.
\nRecommendations for ethical approaches to genotype-driven research recruitment.
\nHum Genet. 2012 Sep;131(9):1423-31. doi: 10.1007\/s00439-012-1177-z. Epub 2012 May
\n24. PubMed PMID: 22622788; PubMed Central PMCID: PMC3686635.<\/p>\n
71: Bailey DB Jr, Skinner D, Davis AM, Whitmarsh I, Powell C. Ethical, legal, and
\nsocial concerns about expanded newborn screening: fragile X syndrome as a
\nprototype for emerging issues. Pediatrics. 2008 Mar;121(3):e693-704. doi:
\n10.1542\/peds.2007-0820. Review. PubMed PMID: 18310190.<\/p>\n
72: Whitmarsh I, Davis AM, Skinner D, Bailey DB Jr. A place for genetic
\nuncertainty: parents valuing an unknown in the meaning of disease. Soc Sci Med.
\n2007 Sep;65(6):1082-93. Epub 2007 Jun 11. PubMed PMID: 17561324; PubMed Central
\nPMCID: PMC2267724.<\/p>\n
73: Vora NL, Powell B, Brandt A, Strande N, Hardisty E, Gilmore K, Foreman AKM,
\nWilhelmsen K, Bizon C, Reilly J, Owen P, Powell CM, Skinner D, Rini C, Lyerly AD,
\nBoggess KA, Weck K, Berg JS, Evans JP. Prenatal exome sequencing in anomalous
\nfetuses: new opportunities and challenges. Genet Med. 2017 Nov;19(11):1207-1216.
\ndoi: 10.1038\/gim.2017.33. Epub 2017 May 18. PubMed PMID: 28518170; PubMed Central
\nPMCID: PMC5675748.<\/p>\n
74: Skinner D, Raspberry KA, King M. The nuanced negative: Meanings of a negative
\ndiagnostic result in clinical exome sequencing. Sociol Health Illn. 2016
\nNov;38(8):1303-1317. doi: 10.1111\/1467-9566.12460. Epub 2016 Aug 19. PubMed PMID:
\n27538589; PubMed Central PMCID: PMC5089912.<\/p>\n
75: Bernhardt BA, Roche MI, Perry DL, Scollon SR, Tomlinson AN, Skinner D.
\nExperiences with obtaining informed consent for genomic sequencing. Am J Med
\nGenet A. 2015 Nov;167A(11):2635-46. doi: 10.1002\/ajmg.a.37256. Epub 2015 Jul 21.
\nPubMed PMID: 26198374; PubMed Central PMCID: PMC4980577.<\/p>\n
76: Tomlinson AN, Skinner D, Perry DL, Scollon SR, Roche MI, Bernhardt BA. “Not
\nTied Up Neatly with a Bow”: Professionals’ Challenging Cases in Informed Consent
\nfor Genomic Sequencing. J Genet Couns. 2016 Feb;25(1):62-72. doi:
\n10.1007\/s10897-015-9842-8. Epub 2015 Apr 26. PubMed PMID: 25911622; PubMed
\nCentral PMCID: PMC4621265.<\/p>\n
77: Haase R, Michie M, Skinner D. Flexible positions, managed hopes: the
\npromissory bioeconomy of a whole genome sequencing cancer study. Soc Sci Med.
\n2015 Apr;130:146-53. doi: 10.1016\/j.socscimed.2015.02.016. Epub 2015 Feb 13.
\nPubMed PMID: 25697637; PubMed Central PMCID: PMC4363274.<\/p>\n
78: Abrams L, Cronister A, Brown WT, Tassone F, Sherman SL, Finucane B,
\nMcConkie-Rosell A, Hagerman R, Kaufmann WE, Picker J, Coffey S, Skinner D,
\nJohnson V, Miller R, Berry-Kravis E. Newborn, carrier, and early childhood
\nscreening recommendations for fragile X. Pediatrics. 2012 Dec;130(6):1126-35.
\ndoi: 10.1542\/peds.2012-0693. Epub 2012 Nov 5. Review. PubMed PMID: 23129072.<\/p>\n
79: Skinner D, Choudhury S, Sideris J, Guarda S, Buansi A, Roche M, Powell C,
\nBailey DB Jr. Parents’ decisions to screen newborns for FMR1 gene expansions in a
\npilot research project. Pediatrics. 2011 Jun;127(6):e1455-63. doi:
\n10.1542\/peds.2010-3078. Epub 2011 May 29. PubMed PMID: 21624881; PubMed Central
\nPMCID: PMC3103273.<\/p>\n
80: Raspberry KA, Skinner D. Negotiating desires and options: how mothers who
\ncarry the fragile X gene experience reproductive decisions. Soc Sci Med. 2011
\nMar;72(6):992-8. doi: 10.1016\/j.socscimed.2011.01.010. Epub 2011 Feb 3. PubMed
\nPMID: 21333433; PubMed Central PMCID: PMC3070848.<\/p>\n
81: Raspberry K, Skinner D. Enacting genetic responsibility: experiences of
\nmothers who carry the fragile X gene. Sociol Health Illn. 2011 Mar;33(3):420-33.
\ndoi: 10.1111\/j.1467-9566.2010.01289.x. Epub 2010 Nov 5. PubMed PMID: 21054442;
\nPubMed Central PMCID: PMC3057279.<\/p>\n
82: Bailey DB Jr, Skinner D, Roche MI, Powell C. Emerging dilemmas in newborn
\nscreening. Virtual Mentor. 2009 Sep 1;11(9):709-13. doi:
\n10.1001\/virtualmentor.2009.11.9.pfor2-0909. PubMed PMID: 23199468.<\/p>\n
83: Roche MI, Skinner D. How parents search, interpret, and evaluate genetic
\ninformation obtained from the internet. J Genet Couns. 2009 Apr;18(2):119-29.
\ndoi: 10.1007\/s10897-008-9198-4. Epub 2008 Oct 21. PubMed PMID: 18937062; PubMed
\nCentral PMCID: PMC3114943.<\/p>\n
84: Bailey DB Jr, Armstrong FD, Kemper AR, Skinner D, Warren SF. Supporting
\nfamily adaptation to presymptomatic and “untreatable” conditions in an era of
\nexpanded newborn screening. J Pediatr Psychol. 2009 Jul;34(6):648-61. doi:
\n10.1093\/jpepsy\/jsn032. Epub 2008 Mar 30. PubMed PMID: 18378512; PubMed Central
\nPMCID: PMC2722102.<\/p>\n
85: Schaffer R, Kuczynski K, Skinner D. Producing genetic knowledge and
\ncitizenship through the Internet: mothers, pediatric genetics, and cybermedicine.
\nSociol Health Illn. 2008 Jan;30(1):145-59. doi: 10.1111\/j.1467-9566.2007.01042.x.
\nPubMed PMID: 18254838.<\/p>\n
86: Raspberry K, Skinner D. Experiencing the genetic body: parents’ encounters
\nwith pediatric clinical genetics. Med Anthropol. 2007 Oct-Dec;26(4):355-91.
\nPubMed PMID: 17943604.<\/p>\n
87: Bailey DB Jr, Beskow LM, Davis AM, Skinner D. Changing perspectives on the
\nbenefits of newborn screening. Ment Retard Dev Disabil Res Rev. 2006;12(4):270-9.
\nPubMed PMID: 17183569.<\/p>\n
88: Conley JM, Cook-Deegan R, L\u00e1zaro-Mu\u00f1oz G. MYRIAD AFTER MYRIAD: THE
\nPROPRIETARY DATA DILEMMA. N C J Law Technol. 2014 Jun;15(4):597-637. PubMed PMID:
\n25544836; PubMed Central PMCID: PMC4275833.<\/p>\n
89: Cook-Deegan R, Conley JM, Evans JP, Vorhaus D. The next controversy in
\ngenetic testing: clinical data as trade secrets? Eur J Hum Genet. 2013
\nJun;21(6):585-8. doi: 10.1038\/ejhg.2012.217. Epub 2012 Nov 14. PubMed PMID:
\n23150081; PubMed Central PMCID: PMC3658186.<\/p>\n
90: Conley JM, Doerr AK, Vorhaus DB. Enabling responsible public genomics. Health
\nMatrix Clevel. 2010;20(2):325-85. PubMed PMID: 21243847.<\/p>\n
91: Webber EM, Hunter JE, Biesecker LG, Buchanan AH, Clarke EV, Currey E,
\nDagan-Rosenfeld O, Lee K, Lindor NM, Martin CL, Milosavljevic A, Mittendorf KF,
\nMuessig KR, O’Daniel JM, Patel RY, Ramos EM, Rego S, Slavotinek AM, Sobriera NLM,
\nWeaver MA, Williams MS, Evans JP, Goddard KAB; ClinGen Resource. Evidence-based
\nassessments of clinical actionability in the context of secondary findings:
\nUpdates from ClinGen’s Actionability Working Group. Hum Mutat. 2018
\nNov;39(11):1677-1685. doi: 10.1002\/humu.23631. PubMed PMID: 30311382.<\/p>\n
92: Haskell GT, Adams MC, Fan Z, Amin K, Guzman Badillo RJ, Zhou L, Bizon C,
\nChahin N, Greenwood RS, Milko LV, Shiloh-Malawsky Y, Crooks KR, Strande N,
\nTennison M, Tilley CR, Brandt A, Wilhelmsen KC, Weck K, Evans JP, Berg JS.
\nDiagnostic utility of exome sequencing in the evaluation of neuromuscular
\ndisorders. Neurol Genet. 2018 Feb 1;4(1):e212. doi: 10.1212\/NXG.0000000000000212.
\neCollection 2018 Feb. PubMed PMID: 29417091; PubMed Central PMCID: PMC5798313.<\/p>\n
93: Bush LW, Beck AE, Biesecker LG, Evans JP, Hamosh A, Holm IA, Martin CL,
\nRichards CS, Rehm HL. Professional responsibilities regarding the provision,
\npublication, and dissemination of patient phenotypes in the context of clinical
\ngenetic and genomic testing: points to consider-a statement of the American
\nCollege of Medical Genetics and Genomics (ACMG). Genet Med. 2018
\nFeb;20(2):169-171. doi: 10.1038\/gim.2017.242. Epub 2018 Jan 11. PubMed PMID:
\n29323668; PubMed Central PMCID: PMC5931217.<\/p>\n
94: Evans JP, Powell BC, Berg JS. Finding the Rare Pathogenic Variants in a Human
\nGenome. JAMA. 2017 May 9;317(18):1904-1905. doi: 10.1001\/jama.2017.0432. PubMed
\nPMID: 28492888.<\/p>\n
95: Allyse M, Evans JP, Michie M. Dr. Pangloss’s Clinic: Prenatal Whole Genome
\nSequencing and a Return to Reality. Am J Bioeth. 2017 Jan;17(1):21-23. PubMed
\nPMID: 27996895; PubMed Central PMCID: PMC5333773.<\/p>\n
96: May T, Strong KA, Zusevics KL, Jeruzal J, Farrell MH, LaPean Kirschner A,
\nDerse AR, Evans JP, Grotevant HD. Does Lack of “Genetic-Relative Family Health
\nHistory” Represent a Potentially Avoidable Health Disparity for Adoptees? Am J
\nBioeth. 2016 Dec;16(12):33-38. PubMed PMID: 27901440.<\/p>\n
97: May T, Evans JP, Strong KA, Zusevics KL, Derse AR, Jeruzal J, LaPean
\nKirschner A, Farrell MH, Grotevant HD. Issues of “Cost, Capabilities, and Scope”
\nin Characterizing Adoptees’ Lack of “Genetic-Relative Family Health History” as
\nan Avoidable Health Disparity: Response to Open Peer Commentaries on “Does Lack
\nof ‘Genetic-Relative Family Health History’ Represent a Potentially Avoidable
\nHealth Disparity for Adoptees?” Am J Bioeth. 2016 Dec;16(12):W4-W8. PubMed PMID:
\n27901431.<\/p>\n
98: Kalia SS, Adelman K, Bale SJ, Chung WK, Eng C, Evans JP, Herman GE, Hufnagel
\nSB, Klein TE, Korf BR, McKelvey KD, Ormond KE, Richards CS, Vlangos CN, Watson M,
\nMartin CL, Miller DT. Recommendations for reporting of secondary findings in
\nclinical exome and genome sequencing, 2016 update (ACMG SF v2.0): a policy
\nstatement of the American College of Medical Genetics and Genomics. Genet Med.
\n2017 Feb;19(2):249-255. doi: 10.1038\/gim.2016.190. Epub 2016 Nov 17. Erratum in:
\nGenet Med. 2017 Apr;19(4):484. PubMed PMID: 27854360.<\/p>\n
99: O’Daniel JM, McLaughlin HM, Amendola LM, Bale SJ, Berg JS, Bick D, Bowling
\nKM, Chao EC, Chung WK, Conlin LK, Cooper GM, Das S, Deignan JL, Dorschner MO,
\nEvans JP, Ghazani AA, Goddard KA, Gornick M, Farwell Hagman KD, Hambuch T, Hegde
\nM, Hindorff LA, Holm IA, Jarvik GP, Knight Johnson A, Mighion L, Morra M, Plon
\nSE, Punj S, Richards CS, Santani A, Shirts BH, Spinner NB, Tang S, Weck KE, Wolf
\nSM, Yang Y, Rehm HL. A survey of current practices for genomic sequencing test
\ninterpretation and reporting processes in US laboratories. Genet Med. 2017
\nMay;19(5):575-582. doi: 10.1038\/gim.2016.152. Epub 2016 Nov 3. PubMed PMID:
\n27811861; PubMed Central PMCID: PMC5415437.<\/p>\n
100: Evans JP. (Mis)understanding Science: The Problem with Scientific
\nBreakthroughs. Hastings Cent Rep. 2016 Sep;46(5):11-3. doi: 10.1002\/hast.611.
\nPubMed PMID: 27649823.<\/p>\n
101: Hunter JE, Irving SA, Biesecker LG, Buchanan A, Jensen B, Lee K, Martin CL,
\nMilko L, Muessig K, Niehaus AD, O’Daniel J, Piper MA, Ramos EM, Schully SD, Scott
\nAF, Slavotinek A, Sobreira N, Strande N, Weaver M, Webber EM, Williams MS, Berg
\nJS, Evans JP, Goddard KA. A standardized, evidence-based protocol to assess
\nclinical actionability of genetic disorders associated with genomic variation.
\nGenet Med. 2016 Dec;18(12):1258-1268. doi: 10.1038\/gim.2016.40. Epub 2016 Apr 28.
\nPubMed PMID: 27124788; PubMed Central PMCID: PMC5085884.<\/p>\n
102: Khoury MJ, Evans JP. A public health perspective on a national precision
\nmedicine cohort: balancing long-term knowledge generation with early health
\nbenefit. JAMA. 2015 Jun 2;313(21):2117-8. doi: 10.1001\/jama.2015.3382. PubMed
\nPMID: 26034952; PubMed Central PMCID: PMC4685667.<\/p>\n
103: Rehm HL, Berg JS, Brooks LD, Bustamante CD, Evans JP, Landrum MJ, Ledbetter
\nDH, Maglott DR, Martin CL, Nussbaum RL, Plon SE, Ramos EM, Sherry ST, Watson MS;
\nClinGen. ClinGen–the Clinical Genome Resource. N Engl J Med. 2015 Jun
\n4;372(23):2235-42. doi: 10.1056\/NEJMsr1406261. Epub 2015 May 27. PubMed PMID:
\n26014595; PubMed Central PMCID: PMC4474187.<\/p>\n
104: Janssens AC, Evans JP. Returning pharmacogenetic secondary findings from
\ngenome sequencing: let’s not put the cart before the horse. Genet Med. 2015
\nNov;17(11):854-6. doi: 10.1038\/gim.2015.59. Epub 2015 May 7. PubMed PMID:
\n25950734.<\/p>\n
105: Lee K, Berg JS, Milko L, Crooks K, Lu M, Bizon C, Owen P, Wilhelmsen KC,
\nWeck KE, Evans JP, Garg S. High Diagnostic Yield of Whole Exome Sequencing in
\nParticipants With Retinal Dystrophies in a Clinical Ophthalmology Setting. Am J
\nOphthalmol. 2015 Aug;160(2):354-363.e9. doi: 10.1016\/j.ajo.2015.04.026. Epub 2015
\nApr 22. PubMed PMID: 25910913; PubMed Central PMCID: PMC4506879.<\/p>\n
106: May T, Strong KA, Khoury MJ, Evans JP. Can targeted genetic testing offer
\nuseful health information to adoptees? Genet Med. 2015 Jul;17(7):533-5. doi:
\n10.1038\/gim.2015.58. Epub 2015 Apr 23. PubMed PMID: 25905442; PubMed Central
\nPMCID: PMC4701205.<\/p>\n
107: Amendola LM, Dorschner MO, Robertson PD, Salama JS, Hart R, Shirts BH,
\nMurray ML, Tokita MJ, Gallego CJ, Kim DS, Bennett JT, Crosslin DR, Ranchalis J,
\nJones KL, Rosenthal EA, Jarvik ER, Itsara A, Turner EH, Herman DS, Schleit J,
\nBurt A, Jamal SM, Abrudan JL, Johnson AD, Conlin LK, Dulik MC, Santani A,
\nMetterville DR, Kelly M, Foreman AK, Lee K, Taylor KD, Guo X, Crooks K,
\nKiedrowski LA, Raffel LJ, Gordon O, Machini K, Desnick RJ, Biesecker LG, Lubitz
\nSA, Mulchandani S, Cooper GM, Joffe S, Richards CS, Yang Y, Rotter JI, Rich SS,
\nO’Donnell CJ, Berg JS, Spinner NB, Evans JP, Fullerton SM, Leppig KA, Bennett RL,
\nBird T, Sybert VP, Grady WM, Tabor HK, Kim JH, Bamshad MJ, Wilfond B, Motulsky
\nAG, Scott CR, Pritchard CC, Walsh TD, Burke W, Raskind WH, Byers P, Hisama FM,
\nRehm H, Nickerson DA, Jarvik GP. Actionable exomic incidental findings in 6503
\nparticipants: challenges of variant classification. Genome Res. 2015
\nMar;25(3):305-15. doi: 10.1101\/gr.183483.114. Epub 2015 Jan 30. PubMed PMID:
\n25637381; PubMed Central PMCID: PMC4352885.<\/p>\n
108: Evans JP, Watson MS. Genetic testing and FDA regulation: overregulation
\nthreatens the emergence of genomic medicine. JAMA. 2015 Feb 17;313(7):669-70.
\ndoi: 10.1001\/jama.2014.18145. PubMed PMID: 25560537.<\/p>\n
109: Jarvik GP, Amendola LM, Berg JS, Brothers K, Clayton EW, Chung W, Evans BJ,
\nEvans JP, Fullerton SM, Gallego CJ, Garrison NA, Gray SW, Holm IA, Kullo IJ,
\nLehmann LS, McCarty C, Prows CA, Rehm HL, Sharp RR, Salama J, Sanderson S, Van
\nDriest SL, Williams MS, Wolf SM, Wolf WA; eMERGE Act-ROR Committee and CERC
\nCommittee; CSER Act-ROR Working\u00a0Group, Burke W. Return of genomic results to
\nresearch participants: the floor, the ceiling, and the choices in between. Am J
\nHum Genet. 2014 Jun 5;94(6):818-26. doi: 10.1016\/j.ajhg.2014.04.009. Epub 2014
\nMay 8. PubMed PMID: 24814192; PubMed Central PMCID: PMC4121476.<\/p>\n
110: Foreman AK, Lee K, Evans JP. The NCGENES project: exploring the new world of
\ngenome sequencing. N C Med J. 2013 Nov-Dec;74(6):500-4. PubMed PMID: 24316776.<\/p>\n
111: Adams SD, Evans JP, Aylsworth AS. Direct-to-consumer genomic testing offers
\nlittle clinical utility but appears to cause minimal harm. N C Med J. 2013
\nNov-Dec;74(6):494-8. PubMed PMID: 24316774.<\/p>\n
112: Berg JS, Amendola LM, Eng C, Van Allen E, Gray SW, Wagle N, Rehm HL, DeChene
\nET, Dulik MC, Hisama FM, Burke W, Spinner NB, Garraway L, Green RC, Plon S, Evans
\nJP, Jarvik GP; Members of the CSER Actionability and Return of Results Working
\nGroup. Processes and preliminary outputs for identification of actionable genes
\nas incidental findings in genomic sequence data in the Clinical Sequencing
\nExploratory Research Consortium. Genet Med. 2013 Nov;15(11):860-7. doi:
\n10.1038\/gim.2013.133. Epub 2013 Oct 24. Review. Erratum in: Genet Med. 2014
\nFeb;16(2):203. PubMed PMID: 24195999; PubMed Central PMCID: PMC3935342.<\/p>\n
113: Evans JP. Finding common ground. Genet Med. 2013 Nov;15(11):852-3. doi:
\n10.1038\/gim.2013.150. Epub 2013 Oct 17. PubMed PMID: 24136615.<\/p>\n
114: Evans JP. Return of results to the families of children in genomic
\nsequencing: tallying risks and benefits. Genet Med. 2013 Jun;15(6):435-6. doi:
\n10.1038\/gim.2013.54. PubMed PMID: 23739673.<\/p>\n
115: Evans JP. When is a medical finding “incidental”? Genet Med. 2013
\nJul;15(7):515-6. doi: 10.1038\/gim.2013.74. Epub 2013 May 30. PubMed PMID:
\n23722872.<\/p>\n
116: McGuire AL, McCullough LB, Evans JP. The indispensable role of professional
\njudgment in genomic medicine. JAMA. 2013 Apr 10;309(14):1465-6. doi:
\n10.1001\/jama.2013.1438. PubMed PMID: 23571582; PubMed Central PMCID: PMC3760691.<\/p>\n
117: Evans JP, Berg JS, Olshan AF, Magnuson T, Rimer BK. We screen newborns,
\ndon’t we?: realizing the promise of public health genomics. Genet Med. 2013
\nMay;15(5):332-4. doi: 10.1038\/gim.2013.11. Epub 2013 Mar 7. Review. PubMed PMID:
\n23470837; PubMed Central PMCID: PMC4789099.<\/p>\n
118: Evans JP, Khoury MJ. The arrival of genomic medicine to the clinic is only
\nthe beginning of the journey. Genet Med. 2013 Apr;15(4):268-9. doi:
\n10.1038\/gim.2012.133. Epub 2013 Jan 10. PubMed PMID: 23306801; PubMed Central
\nPMCID: PMC4693143.<\/p>\n
119: Dobson AW, Evans JP. Gene patents in the US–focusing on what really
\nmatters. Genome Biol. 2012 Jun 29;13(6):161. doi: 10.1186\/gb-2012-13-6-161.
\nPubMed PMID: 22748211; PubMed Central PMCID: PMC3446309.<\/p>\n
120: Evans JP, Rothschild BB. Return of results: not that complicated? Genet Med.
\n2012 Apr;14(4):358-60. doi: 10.1038\/gim.2012.8. PubMed PMID: 22481183.<\/p>\n
121: Green RC, Berg JS, Berry GT, Biesecker LG, Dimmock DP, Evans JP, Grody WW,
\nHegde MR, Kalia S, Korf BR, Krantz I, McGuire AL, Miller DT, Murray MF, Nussbaum
\nRL, Plon SE, Rehm HL, Jacob HJ. Exploring concordance and discordance for return
\nof incidental findings from clinical sequencing. Genet Med. 2012
\nApr;14(4):405-10. doi: 10.1038\/gim.2012.21. Epub 2012 Mar 15. PubMed PMID:
\n22422049; PubMed Central PMCID: PMC3763716.<\/p>\n
122: Evans JP, Berg JS. Next-generation DNA sequencing, regulation, and the
\nlimits of paternalism: the next challenge. JAMA. 2011 Dec 7;306(21):2376-7. doi:
\n10.1001\/jama.2011.1788. PubMed PMID: 22147382.<\/p>\n
123: Spencer DH, Lockwood C, Topol E, Evans JP, Green RC, Mansfield E, Tezak Z.
\nDirect-to-consumer genetic testing: reliable or risky? Clin Chem. 2011
\nDec;57(12):1641-4. doi: 10.1373\/clinchem.2011.167197. Epub 2011 Sep 1. PubMed
\nPMID: 21885623.<\/p>\n
124: Dreyfuss R, Evans JP. From Bilski back to Benson: preemption, inventing
\naround, and the case of genetic diagnostics. Stanford Law Rev. 2011
\nJun;63(6):1349-76. PubMed PMID: 21774194.<\/p>\n
125: Burke W, Tarini B, Press NA, Evans JP. Genetic screening. Epidemiol Rev.
\n2011;33:148-64. doi: 10.1093\/epirev\/mxr008. Epub 2011 Jun 27. Review. PubMed
\nPMID: 21709145; PubMed Central PMCID: PMC3166195.<\/p>\n
126: Evans JP. That personal touch. Hastings Cent Rep. 2011 May-Jun;41(3):5-6.
\nPubMed PMID: 21678801.<\/p>\n
127: Berg JS, Khoury MJ, Evans JP. Deploying whole genome sequencing in clinical
\npractice and public health: meeting the challenge one bin at a time. Genet Med.
\n2011 Jun;13(6):499-504. doi: 10.1097\/GIM.0b013e318220aaba. PubMed PMID: 21558861.<\/p>\n
128: Khoury MJ, Bowen MS, Burke W, Coates RJ, Dowling NF, Evans JP, Reyes M, St
\nPierre J. Current priorities for public health practice in addressing the role of
\nhuman genomics in improving population health. Am J Prev Med. 2011
\nApr;40(4):486-93. doi: 10.1016\/j.amepre.2010.12.009. PubMed PMID: 21406285;
\nPubMed Central PMCID: PMC5624316.<\/p>\n
129: Evans JP. Looking ahead, looking behind. Introduction. Genet Med. 2011
\nMar;13(3):177-8. doi: 10.1097\/GIM.0b013e318210b0a7. PubMed PMID: 21346480.<\/p>\n
130: Evans JP, Meslin EM, Marteau TM, Caulfield T. Genomics. Deflating the
\ngenomic bubble. Science. 2011 Feb 18;331(6019):861-2. doi:
\n10.1126\/science.1198039. PubMed PMID: 21330519.<\/p>\n
131: Khoury MJ, Coates RJ, Evans JP. Evidence-based classification of
\nrecommendations on use of genomic tests in clinical practice: dealing with
\ninsufficient evidence. Genet Med. 2010 Nov;12(11):680-3. doi:
\n10.1097\/GIM.0b013e3181f9ad55. PubMed PMID: 20975567.<\/p>\n
132: Evans JP, Dale DC, Fomous C. Preparing for a consumer-driven genomic age. N
\nEngl J Med. 2010 Sep 16;363(12):1099-103. doi: 10.1056\/NEJMp1006202. Epub 2010
\nAug 18. PubMed PMID: 20843241.<\/p>\n
133: Evans JP. The Human Genome Project at 10 years: a teachable moment. Genet
\nMed. 2010 Aug;12(8):477. doi: 10.1097\/GIM.0b013e3181ef16b6. PubMed PMID:
\n20703139.<\/p>\n
134: Evans JP, Burke W, Khoury M. The rules remain the same for genomic medicine:
\nthe case against “reverse genetic exceptionalism”. Genet Med. 2010
\nJun;12(6):342-3. doi: 10.1097\/GIM.0b013e3181deb308. PubMed PMID: 20556868.<\/p>\n
135: Evans JP. Putting patients before patents. Genet Med. 2010 Apr;12(4):204-5.
\ndoi: 10.1097\/GIM.0b013e3181d74c1c. PubMed PMID: 20395743.<\/p>\n
136: Evans JP. The Origin. Genet Med. 2009 Nov;11(11):776-7. doi:
\n10.1097\/GIM.0b013e3181c03a17. PubMed PMID: 19938246.<\/p>\n
137: Ader T, Susswein LR, Callanan NP, Evans JP. Attitudes and practice of
\ngenetic counselors regarding anonymous testing for BRCA1\/2. J Genet Couns. 2009
\nDec;18(6):606-17. doi: 10.1007\/s10897-009-9250-z. Epub 2009 Oct 2. PubMed PMID:
\n19798553.<\/p>\n
138: Grosse SD, McBride CM, Evans JP, Khoury MJ. Personal utility and genomic
\ninformation: look before you leap. Genet Med. 2009 Aug;11(8):575-6. doi:
\n10.1097\/GIM.0b013e3181af0a80. PubMed PMID: 19623080; PubMed Central PMCID:
\nPMC3417335.<\/p>\n
139: Evans JP, Green RC. Direct to consumer genetic testing: Avoiding a culture
\nwar. Genet Med. 2009 Aug;11(8):568-9. doi: 10.1097\/GIM.0b013e3181afbaed. PubMed
\nPMID: 19606051; PubMed Central PMCID: PMC2920210.<\/p>\n
140: Evans JP. The voyage continues: Darwin and medicine at 200 years. JAMA. 2009
\nFeb 11;301(6):663-5. doi: 10.1001\/jama.2009.102. PubMed PMID: 19211473.<\/p>\n
141: Evans JP. Recreational genomics; what’s in it for you? Genet Med. 2008
\nOct;10(10):709-10. doi: 10.1097\/GIM.0b013e3181859959. PubMed PMID: 18813136;
\nPubMed Central PMCID: PMC2672622.<\/p>\n
142: Evans JP, Burke W. Genetic exceptionalism. Too much of a good thing? Genet
\nMed. 2008 Jul;10(7):500-1. doi: 10.1097GIM.0b013e31817f280a. PubMed PMID:
\n18580684.<\/p>\n
143: Robin NH, Evans JP. Why physicians must understand evolution. Curr Opin
\nPediatr. 2009 Dec;21(6):699-702. doi: 10.1097\/MOP.0b013e3283323aa8. Review.
\nPubMed PMID: 19770767.<\/p>\n
144: Evans JP. Health care in the age of genetic medicine. Genet Med. 2008
\nJan;10(1):1-3. doi: 10.1097\/GIM.0b013e318164c669. Review. PubMed PMID: 18197050.<\/p>\n
145: Susswein LR, Skrzynia C, Lange LA, Booker JK, Graham ML 3rd, Evans JP.
\nIncreased uptake of BRCA1\/2 genetic testing among African American women with a
\nrecent diagnosis of breast cancer. J Clin Oncol. 2008 Jan 1;26(1):32-6. doi:
\n10.1200\/JCO.2007.10.6377. PubMed PMID: 18165638.<\/p>\n
146: Evans JP. Health care in the age of genetic medicine. JAMA. 2007 Dec
\n12;298(22):2670-2. PubMed PMID: 18073364.<\/p>\n
147: Evans JP. A future for medical genetics: lessons from Catch 22. Genet Med.
\n2007 Jan;9(1):1-3. PubMed PMID: 17224683.<\/p>\n
148: Evans JP. Celebrating the birthday of our intellectual common ancestor.
\nGenet Med. 2007 Feb;9(2):63-4. PubMed PMID: 17304045.<\/p>\n
149: Milko LV, Rini C, Lewis MA, Butterfield RM, Lin FC, Paquin RS, Powell BC,
\nRoche MI, Souris KJ, Bailey DB Jr, Berg JS, Powell CM. Evaluating parents’
\ndecisions about next-generation sequencing for their child in the NC NEXUS (North
\nCarolina Newborn Exome Sequencing for Universal Screening) study: a randomized
\ncontrolled trial protocol. Trials. 2018 Jun 28;19(1):344. doi:
\n10.1186\/s13063-018-2686-4. PubMed PMID: 29950170; PubMed Central PMCID:
\nPMC6022715.<\/p>\n
150: Ormond KE, Hallquist MLG, Buchanan AH, Dondanville D, Cho MK, Smith M, Roche
\nM, Brothers KB, Coughlin CR 2nd, Hercher L, Hudgins L, Jamal S, Levy HP, Raskin
\nM, Stosic M, Uhlmann W, Wain KE, Currey E, Faucett WA. Developing a conceptual,
\nreproducible, rubric-based approach to consent and result disclosure for genetic
\ntesting by clinicians with minimal genetics background. Genet Med. 2018 Jul 6.
\ndoi: 10.1038\/s41436-018-0093-6. [Epub ahead of print] PubMed PMID: 29976988.<\/p>\n
151: Amendola LM, Robinson JO, Hart R, Biswas S, Lee K, Bernhardt BA, East K,
\nGilmore MJ, Kauffman TL, Lewis KL, Roche M, Scollon S, Wynn J, Blout C. Why
\nPatients Decline Genomic Sequencing Studies: Experiences from the CSER
\nConsortium. J Genet Couns. 2018 Sep;27(5):1220-1227. doi:
\n10.1007\/s10897-018-0243-7. Epub 2018 Mar 1. PubMed PMID: 29497922; PubMed Central
\nPMCID: PMC6119550.<\/p>\n
152: Lewis MA, Stine A, Paquin RS, Mansfield C, Wood D, Rini C, Roche MI, Powell
\nCM, Berg JS, Bailey DB Jr. Parental preferences toward genomic sequencing for
\nnon-medically actionable conditions in children: a discrete-choice experiment.
\nGenet Med. 2018 Feb;20(2):181-189. doi: 10.1038\/gim.2017.93. Epub 2017 Aug 3.
\nPubMed PMID: 28771249; PubMed Central PMCID: PMC5868968.<\/p>\n
153: Berg JS, Agrawal PB, Bailey DB Jr, Beggs AH, Brenner SE, Brower AM, Cakici
\nJA, Ceyhan-Birsoy O, Chan K, Chen F, Currier RJ, Dukhovny D, Green RC, Harris-Wai
\nJ, Holm IA, Iglesias B, Joseph G, Kingsmore SF, Koenig BA, Kwok PY, Lantos J,
\nLeeder SJ, Lewis MA, McGuire AL, Milko LV, Mooney SD, Parad RB, Pereira S,
\nPetrikin J, Powell BC, Powell CM, Puck JM, Rehm HL, Risch N, Roche M, Shieh JT,
\nVeeraraghavan N, Watson MS, Willig L, Yu TW, Urv T, Wise AL. Newborn Sequencing
\nin Genomic Medicine and Public Health. Pediatrics. 2017 Feb;139(2). pii:
\ne20162252. doi: 10.1542\/peds.2016-2252. Epub 2017 Jan 17. PubMed PMID: 28096516;
\nPubMed Central PMCID: PMC5260149.<\/p>\n
154: Langer MM, Roche MI, Brewer NT, Berg JS, Khan CM, Leos C, Moore E, Brown M,
\nRini C. Development and Validation of a Genomic Knowledge Scale to Advance
\nInformed Decision Making Research in Genomic Sequencing. MDM Policy Pract. 2017
\nJan-Jun;2(1). doi: 10.1177\/2381468317692582. Epub 2017 Feb 1. PubMed PMID:
\n29928697; PubMed Central PMCID: PMC6005662.<\/p>\n
155: Lewis MA, Paquin RS, Roche MI, Furberg RD, Rini C, Berg JS, Powell CM,
\nBailey DB Jr. Supporting Parental Decisions About Genomic Sequencing for Newborn
\nScreening: The NC NEXUS Decision Aid. Pediatrics. 2016 Jan;137 Suppl 1:S16-23.
\ndoi: 10.1542\/peds.2015-3731E. PubMed PMID: 26729698; PubMed Central PMCID:
\nPMC4922487.<\/p>\n
156: Roche MI, Berg JS. Incidental Findings with Genomic Testing: Implications
\nfor Genetic Counseling Practice. Curr Genet Med Rep. 2015;3(4):166-176. Epub 2015
\nAug 25. Review. PubMed PMID: 26566463; PubMed Central PMCID: PMC4633435.<\/p>\n
157: Bailey DB Jr, Wheeler A, Berry-Kravis E, Hagerman R, Tassone F, Powell CM,
\nRoche M, Gane LW, Sideris J. Maternal Consequences of the Detection of Fragile X
\nCarriers in Newborn Screening. Pediatrics. 2015 Aug;136(2):e433-40. doi:
\n10.1542\/peds.2015-0414. Epub 2015 Jul 13. PubMed PMID: 26169437; PubMed Central
\nPMCID: PMC4516945.<\/p>\n
158: Prince AE, Roche MI. Genetic information, non-discrimination, and privacy
\nprotections in genetic counseling practice. J Genet Couns. 2014
\nDec;23(6):891-902. doi: 10.1007\/s10897-014-9743-2. Epub 2014 Jul 27. PubMed PMID:
\n25063358; PubMed Central PMCID: PMC4233176.<\/p>\n
159: Roche MI, Palmer CG. Next generation genetic counseling: introduction to the
\nspecial issue. J Genet Couns. 2014 Aug;23(4):439-44. doi:
\n10.1007\/s10897-014-9729-0. Epub 2014 May 18. PubMed PMID: 24838698; PubMed
\nCentral PMCID: PMC4096054.<\/p>\n
160: Clayton EW, McCullough LB, Biesecker LG, Joffe S, Ross LF, Wolf SM; Clinical
\nSequencing Exploratory Research (CSER) Consortium Pediatrics Working Group.
\nAddressing the ethical challenges in genetic testing and sequencing of children.
\nAm J Bioeth. 2014;14(3):3-9. doi: 10.1080\/15265161.2013.879945. PubMed PMID:
\n24592828; PubMed Central PMCID: PMC3950962.<\/p>\n
161: Bailey DB Jr, Bann C, Bishop E, Guarda S, Barnum L, Roche M. Can a decision
\naid enable informed decisions in neonatal nursery recruitment for a fragile X
\nnewborn screening study? Genet Med. 2013 Apr;15(4):299-306. doi:
\n10.1038\/gim.2012.135. Epub 2012 Oct 25. PubMed PMID: 23100013.<\/p>\n
162: Roche MI. Moving toward NextGenetic counseling. Genet Med. 2012
\nSep;14(9):777-8. doi: 10.1038\/gim.2012.84. Epub 2012 Jul 12. PubMed PMID:
\n22791211.<\/p>\n
163: Bailey DB Jr, Lewis MA, Harris SL, Grant T, Bann C, Bishop E, Roche M,
\nGuarda S, Barnum L, Powell C, Therrell BL Jr. Design and evaluation of a decision
\naid for inviting parents to participate in a fragile X newborn screening pilot
\nstudy. J Genet Couns. 2013 Feb;22(1):108-17. doi: 10.1007\/s10897-012-9511-0. Epub
\n2012 Jun 27. PubMed PMID: 22736213.<\/p>\n
164: Rivera-Mu\u00f1oz EA, Milko LV, Harrison SM, Azzariti DR, Kurtz CL, Lee K, Mester
\nJL, Weaver MA, Currey E, Craigen W, Eng C, Funke B, Hegde M, Hershberger RE, Mao
\nR, Steiner RD, Vincent LM, Martin CL, Plon SE, Ramos E, Rehm HL, Watson M, Berg
\nJS. ClinGen Variant Curation Expert Panel experiences and standardized processes
\nfor disease and gene-level specification of the ACMG\/AMP guidelines for sequence
\nvariant interpretation. Hum Mutat. 2018 Nov;39(11):1614-1622. doi:
\n10.1002\/humu.23645. PubMed PMID: 30311389.<\/p>\n
165: McGlaughon JL, Goldstein JL, Thaxton C, Hemphill SE, Berg JS. The
\nprogression of the ClinGen gene clinical validity classification over time. Hum
\nMutat. 2018 Nov;39(11):1494-1504. doi: 10.1002\/humu.23604. PubMed PMID: 30311372;
\nPubMed Central PMCID: PMC6190678.<\/p>\n
166: Hart MR, Biesecker BB, Blout CL, Christensen KD, Amendola LM, Bergstrom KL,
\nBiswas S, Bowling KM, Brothers KB, Conlin LK, Cooper GM, Dulik MC, East KM,
\nEverett JN, Finnila CR, Ghazani AA, Gilmore MJ, Goddard KAB, Jarvik GP, Johnston
\nJJ, Kauffman TL, Kelley WV, Krier JB, Lewis KL, McGuire AL, McMullen C, Ou J,
\nPlon SE, Rehm HL, Richards CS, Romasko EJ, Miren Sagardia A, Spinner NB, Thompson
\nML, Turbitt E, Vassy JL, Wilfond BS, Veenstra DL, Berg JS, Green RC, Biesecker
\nLG, Hindorff LA. Secondary findings from clinical genomic sequencing: prevalence,
\npatient perspectives, family history assessment, and health-care costs from a
\nmultisite study. Genet Med. 2018 Oct 5. doi: 10.1038\/s41436-018-0308-x. [Epub
\nahead of print] PubMed PMID: 30287922.<\/p>\n
167: Meagher KM, Berg JS. Too much of a good thing? Overdiagnosis, or
\noverestimating risk in preventive genomic screening. Per Med. 2018
\nSep;15(5):343-346. doi: 10.2217\/pme-2018-0041. Epub 2018 Sep 27. PubMed PMID:
\n30260288.<\/p>\n
168: Amendola LM, Berg JS, Horowitz CR, Angelo F, Bensen JT, Biesecker BB,
\nBiesecker LG, Cooper GM, East K, Filipski K, Fullerton SM, Gelb BD, Goddard KAB,
\nHailu B, Hart R, Hassmiller-Lich K, Joseph G, Kenny EE, Koenig BA, Knight S, Kwok
\nPY, Lewis KL, McGuire AL, Norton ME, Ou J, Parsons DW, Powell BC, Risch N,
\nRobinson M, Rini C, Scollon S, Slavotinek AM, Veenstra DL, Wasserstein MP,
\nWilfond BS, Hindorff LA; CSER consortium, Plon SE, Jarvik GP. The Clinical
\nSequencing Evidence-Generating Research Consortium: Integrating Genomic
\nSequencing in Diverse and Medically Underserved Populations. Am J Hum Genet. 2018
\nSep 6;103(3):319-327. doi: 10.1016\/j.ajhg.2018.08.007. PubMed PMID: 30193136;
\nPubMed Central PMCID: PMC6128306.<\/p>\n
169: Milko LV, Funke BH, Hershberger RE, Azzariti DR, Lee K, Riggs ER,
\nRivera-Munoz EA, Weaver MA, Niehaus A, Currey EL, Craigen WJ, Mao R, Offit K,
\nSteiner RD, Martin CL, Rehm HL, Watson MS, Ramos EM, Plon SE, Berg JS.
\nDevelopment of Clinical Domain Working Groups for the Clinical Genome Resource
\n(ClinGen): lessons learned and plans for the future. Genet Med. 2018 Sep 5. doi:
\n10.1038\/s41436-018-0267-2. [Epub ahead of print] PubMed PMID: 30181607.<\/p>\n
170: Porter KM, Kauffman TL, Koenig BA, Lewis KL, Rehm HL, Richards CS, Strande
\nNT, Tabor HK, Wolf SM, Yang Y, Amendola LM, Azzariti DR, Berg JS, Bergstrom K,
\nBiesecker LG, Biswas S, Bowling KM, Chung WK, Clayton EW, Conlin LK, Cooper GM,
\nDulik MC, Garraway LA, Ghazani AA, Green RC, Hiatt SM, Jamal SM, Jarvik GP,
\nGoddard KAB, Wilfond BS; members of the CSER Actionability and Return of Results
\nWorking Group. Approaches to carrier testing and results disclosure in
\ntranslational genomics research: The clinical sequencing exploratory research
\nconsortium experience. Mol Genet Genomic Med. 2018 Aug 21. doi: 10.1002\/mgg3.453.
\n[Epub ahead of print] PubMed PMID: 30133189.<\/p>\n
171: Brnich SE, Rivera-Mu\u00f1oz EA, Berg JS. Quantifying the potential of functional
\nevidence to reclassify variants of uncertain significance in the categorical and
\nBayesian interpretation frameworks. Hum Mutat. 2018 Nov;39(11):1531-1541. doi:
\n10.1002\/humu.23609. Epub 2018 Sep 5. PubMed PMID: 30095857.<\/p>\n
172: Strande NT, Brnich SE, Roman TS, Berg JS. Navigating the nuances of clinical
\nsequence variant interpretation in Mendelian disease. Genet Med. 2018
\nSep;20(9):918-926. doi: 10.1038\/s41436-018-0100-y. Epub 2018 Jul 10. Review.
\nPubMed PMID: 29988079.<\/p>\n
173: Christensen KD, Bernhardt BA, Jarvik GP, Hindorff LA, Ou J, Biswas S, Powell
\nBC, Grundmeier RW, Machini K, Karavite DJ, Pennington JW, Krantz ID, Berg JS,
\nGoddard KAB. Anticipated responses of early adopter genetic specialists and
\nnongenetic specialists to unsolicited genomic secondary findings. Genet Med. 2018
\nFeb 1. doi: 10.1038\/gim.2017.243. [Epub ahead of print] PubMed PMID: 29388940;
\nPubMed Central PMCID: PMC6103906.<\/p>\n
174: Mollison L, Berg JS. Genetic screening: birthright or earned with age?
\nExpert Rev Mol Diagn. 2017 Aug;17(8):735-738. doi: 10.1080\/14737159.2017.1346473.
\nEpub 2017 Jun 29. PubMed PMID: 28641021; PubMed Central PMCID: PMC6086349.<\/p>\n
175: Strande NT, Riggs ER, Buchanan AH, Ceyhan-Birsoy O, DiStefano M, Dwight SS,
\nGoldstein J, Ghosh R, Seifert BA, Sneddon TP, Wright MW, Milko LV, Cherry JM,
\nGiovanni MA, Murray MF, O’Daniel JM, Ramos EM, Santani AB, Scott AF, Plon SE,
\nRehm HL, Martin CL, Berg JS. Evaluating the Clinical Validity of Gene-Disease
\nAssociations: An Evidence-Based Framework Developed by the Clinical Genome
\nResource. Am J Hum Genet. 2017 Jun 1;100(6):895-906. doi:
\n10.1016\/j.ajhg.2017.04.015. Epub 2017 May 25. PubMed PMID: 28552198; PubMed
\nCentral PMCID: PMC5473734.<\/p>\n
176: Green RC, Berg JS, Grody WW, Kalia SS, Korf BR, Martin CL, McGuire AL,
\nNussbaum RL, O’Daniel JM, Ormond KE, Rehm HL, Watson MS, Williams MS, Biesecker
\nLG. CORRIGENDUM: ACMG recommendations for reporting of incidental findings in
\nclinical exome and genome sequencing. Genet Med. 2017 May;19(5):606. doi:
\n10.1038\/gim.2017.18. PubMed PMID: 28492529.<\/p>\n
177: Himes P, Kauffman TL, Muessig KR, Amendola LM, Berg JS, Dorschner MO,
\nGilmore M, Nickerson DA, Reiss JA, Richards CS, Rope AF, Simpson DK, Wilfond BS,
\nJarvik GP, Goddard KAB. Genome sequencing and carrier testing: decisions on
\ncategorization and whether to disclose results of carrier testing. Genet Med.
\n2017 Jul;19(7):803-808. doi: 10.1038\/gim.2016.198. Epub 2017 Jan 12. PubMed PMID:
\n28079899; PubMed Central PMCID: PMC5509491.<\/p>\n
178: O’Daniel JM, Berg JS. A missing link in the bench-to-bedside paradigm:
\nengaging regulatory stakeholders in clinical genomics research. Genome Med. 2016
\nSep 21;8(1):95. PubMed PMID: 27655359; PubMed Central PMCID: PMC5031300.<\/p>\n
179: Berg JS. Exploring the importance of case-level clinical information for
\nvariant interpretation. Genet Med. 2017 Jan;19(1):3-5. doi: 10.1038\/gim.2016.106.
\nEpub 2016 Aug 25. PubMed PMID: 27561084; PubMed Central PMCID: PMC5225022.<\/p>\n
180: Strande NT, Berg JS. Defining the Clinical Value of a Genomic Diagnosis in
\nthe Era of Next-Generation Sequencing. Annu Rev Genomics Hum Genet. 2016 Aug
\n31;17:303-32. doi: 10.1146\/annurev-genom-083115-022348. Epub 2016 May 26. Review.
\nPubMed PMID: 27362341.<\/p>\n
181: Leo MC, McMullen C, Wilfond BS, Lynch FL, Reiss JA, Gilmore MJ, Himes P,
\nKauffman TL, Davis JV, Jarvik GP, Berg JS, Harding C, Kennedy KA, Simpson DK,
\nQuigley DI, Richards CS, Rope AF, Goddard KA. Patients’ ratings of genetic
\nconditions validate a taxonomy to simplify decisions about preconception carrier
\nscreening via genome sequencing. Am J Med Genet A. 2016 Mar;170(3):574-82. doi:
\n10.1002\/ajmg.a.37477. Epub 2016 Jan 21. PubMed PMID: 26792268; PubMed Central
\nPMCID: PMC4824299.<\/p>\n
182: Berg JS, Powell CM. Potential Uses and Inherent Challenges of Using
\nGenome-Scale Sequencing to Augment Current Newborn Screening. Cold Spring Harb
\nPerspect Med. 2015 Oct 5;5(12). pii: a023150. doi: 10.1101\/cshperspect.a023150.
\nReview. PubMed PMID: 26438605; PubMed Central PMCID: PMC4665041.<\/p>\n
183: Botkin JR, Belmont JW, Berg JS, Berkman BE, Bombard Y, Holm IA, Levy HP,
\nOrmond KE, Saal HM, Spinner NB, Wilfond BS, McInerney JD. Points to Consider:
\nEthical, Legal, and Psychosocial Implications of Genetic Testing in Children and
\nAdolescents. Am J Hum Genet. 2015 Jul 2;97(1):6-21. doi:
\n10.1016\/j.ajhg.2015.05.022. Review. Erratum in: Am J Hum Genet. 2015 Sep
\n3;97(3):501. PubMed PMID: 26140447; PubMed Central PMCID: PMC4570999.<\/p>\n
184: Adams MC, Berg JS, Pearlman MD, Vora NL. Look before you leap: genomic
\nscreening in obstetrics and gynecology. Obstet Gynecol. 2015 Jun;125(6):1299-305.
\ndoi: 10.1097\/AOG.0000000000000871. PubMed PMID: 26000500.<\/p>\n
185: Berg JS. Genome-scale sequencing in clinical care: establishing molecular
\ndiagnoses and measuring value. JAMA. 2014 Nov 12;312(18):1865-7. doi:
\n10.1001\/jama.2014.14665. PubMed PMID: 25326641.<\/p>\n
186: Prince AE, Berg JS, Evans JP, Jonas DE, Henderson G. Genomic screening of
\nthe general adult population: key concepts for assessing net benefit with
\nsystematic evidence reviews. Genet Med. 2015 Jun;17(6):441-3. doi:
\n10.1038\/gim.2014.129. Epub 2014 Sep 18. Review. PubMed PMID: 25232850; PubMed
\nCentral PMCID: PMC4387105.<\/p>\n
187: Ramos EM, Din-Lovinescu C, Berg JS, Brooks LD, Duncanson A, Dunn M, Good P,
\nHubbard TJ, Jarvik GP, O’Donnell C, Sherry ST, Aronson N, Biesecker LG, Blumberg
\nB, Calonge N, Colhoun HM, Epstein RS, Flicek P, Gordon ES, Green ED, Green RC,
\nHurles M, Kawamoto K, Knaus W, Ledbetter DH, Levy HP, Lyon E, Maglott D, McLeod
\nHL, Rahman N, Randhawa G, Wicklund C, Manolio TA, Chisholm RL, Williams MS.
\nCharacterizing genetic variants for clinical action. Am J Med Genet C Semin Med
\nGenet. 2014 Mar;166C(1):93-104. doi: 10.1002\/ajmg.c.31386. Epub 2014 Mar 13.
\nPubMed PMID: 24634402; PubMed Central PMCID: PMC4158437.<\/p>\n
188: Krantz MS, Berg JS. Crowdsourcing to define the clinical actionability of
\nincidental findings of genetic testing. N C Med J. 2013 Nov-Dec;74(6):501-2.
\nPubMed PMID: 24316777.<\/p>\n
189: Evaluation of Genomic Applications in Practice and Prevention (EGAPP)
\nWorking Group. The EGAPP initiative: lessons learned. Genet Med. 2014
\nMar;16(3):217-24. doi: 10.1038\/gim.2013.110. Epub 2013 Aug 8. Review. PubMed
\nPMID: 23928914.<\/p>\n
190: Green RC, Berg JS, Grody WW, Kalia SS, Korf BR, Martin CL, McGuire AL,
\nNussbaum RL, O’Daniel JM, Ormond KE, Rehm HL, Watson MS, Williams MS, Biesecker
\nLG; American College of Medical Genetics and Genomics. ACMG recommendations for
\nreporting of incidental findings in clinical exome and genome sequencing. Genet
\nMed. 2013 Jul;15(7):565-74. doi: 10.1038\/gim.2013.73. Epub 2013 Jun 20. Erratum
\nin: Genet Med. 2017 May;19(5):606. PubMed PMID: 23788249; PubMed Central PMCID:
\nPMC3727274.<\/p>\n
191: Goddard KA, Whitlock EP, Berg JS, Williams MS, Webber EM, Webster JA, Lin
\nJS, Schrader KA, Campos-Outcalt D, Offit K, Feigelson HS, Hollombe C. Description
\nand pilot results from a novel method for evaluating return of incidental
\nfindings from next-generation sequencing technologies. Genet Med. 2013
\nSep;15(9):721-8. doi: 10.1038\/gim.2013.37. Epub 2013 Apr 4. PubMed PMID:
\n23558254; PubMed Central PMCID: PMC3927794.<\/p>\n
192: Berg JS, French SL, McCullough LB, Kleppe S, Sutton VR, Gunn SK, Karaviti
\nLP. Ethical and legal implications of genetic testing in androgen insensitivity
\nsyndrome. J Pediatr. 2007 Apr;150(4):434-8. PubMed PMID: 17382127.<\/p>\n
193: Beskow LM, Namey EE, Miller PR, Nelson DK, Cooper A. IRB chairs’
\nperspectives on genotype-driven research recruitment. IRB. 2012
\nMay-Jun;34(3):1-10. PubMed PMID: 22830177; PubMed Central PMCID: PMC3632007.<\/p>\n
194: Schmidlen T, Sturm AC, Hovick S, Scheinfeldt L, Scott Roberts J, Morr L,
\nMcElroy J, Toland AE, Christman M, O’Daniel JM, Gordon ES, Bernhardt BA, Ormond
\nKE, Sweet K. Operationalizing the Reciprocal Engagement Model of Genetic
\nCounseling Practice: a Framework for the Scalable Delivery of Genomic Counseling
\nand Testing. J Genet Couns. 2018 Sep;27(5):1111-1129. doi:
\n10.1007\/s10897-018-0230-z. Epub 2018 Feb 19. PubMed PMID: 29460110; PubMed
\nCentral PMCID: PMC6098987.<\/p>\n
195: Facio FM, Lee K, O’Daniel JM. A genetic counselor’s guide to using
\nnext-generation sequencing in clinical practice. J Genet Couns. 2014
\nAug;23(4):455-62. doi: 10.1007\/s10897-013-9662-7. Epub 2013 Oct 24. PubMed PMID:
\n24151055.<\/p>\n
196: Haga SB, Rosanbalm KD, Boles L, Tindall GM, Livingston TM, O’Daniel JM.
\nPromoting public awareness and engagement in genome sciences. J Genet Couns. 2013
\nAug;22(4):508-16. doi: 10.1007\/s10897-013-9577-3. Epub 2013 Feb 23. PubMed PMID:
\n23435715; PubMed Central PMCID: PMC3688701.<\/p>\n
197: O’Daniel JM, Lee K. Whole-genome and whole-exome sequencing in hereditary
\ncancer: impact on genetic testing and counseling. Cancer J. 2012
\nJul-Aug;18(4):287-92. doi: 10.1097\/PPO.0b013e318262467e. Review. PubMed PMID:
\n22846728.<\/p>\n
198: O’Daniel JM, Rosanbalm KD, Boles L, Tindall GM, Livingston TM, Haga SB.
\nEnhancing geneticists’ perspectives of the public through community engagement.
\nGenet Med. 2012 Feb;14(2):243-9. doi: 10.1038\/gim.2011.29. Epub 2012 Jan 19.
\nPubMed PMID: 22241095.<\/p>\n
199: Haga SB, Tindall G, O’Daniel JM. Public perspectives about pharmacogenetic
\ntesting and managing ancillary findings. Genet Test Mol Biomarkers. 2012
\nMar;16(3):193-7. doi: 10.1089\/gtmb.2011.0118. Epub 2011 Nov 2. PubMed PMID:
\n22047505; PubMed Central PMCID: PMC3306589.<\/p>\n
200: Haga SB, Tindall G, O’Daniel JM. Professional perspectives about
\npharmacogenetic testing and managing ancillary findings. Genet Test Mol
\nBiomarkers. 2012 Jan;16(1):21-4. doi: 10.1089\/gtmb.2011.0045. Epub 2011 Jul 19.
\nPubMed PMID: 21770772; PubMed Central PMCID: PMC3265769.<\/p>\n
201: Haga SB, O’Daniel JM, Tindall GM, Lipkus IR, Agans R. Public attitudes
\ntoward ancillary information revealed by pharmacogenetic testing under limited
\ninformation conditions. Genet Med. 2011 Aug;13(8):723-8. doi:
\n10.1097\/GIM.0b013e31821afcc0. PubMed PMID: 21633294; PubMed Central PMCID:
\nPMC3150617.<\/p>\n
202: Haga SB, Carrig MM, O’Daniel JM, Orlando LA, Killeya-Jones LA, Ginsburg GS,
\nCho A. Genomic risk profiling: attitudes and use in personal and clinical care of
\nprimary care physicians who offer risk profiling. J Gen Intern Med. 2011
\nAug;26(8):834-40. doi: 10.1007\/s11606-011-1651-7. Epub 2011 Feb 11. PubMed PMID:
\n21311998; PubMed Central PMCID: PMC3138989.<\/p>\n
203: O’Daniel JM. The prospect of genome-guided preventive medicine: a need and
\nopportunity for genetic counselors. J Genet Couns. 2010 Aug;19(4):315-27. doi:
\n10.1007\/s10897-010-9302-4. Epub 2010 May 4. PubMed PMID: 20440545.<\/p>\n
204: O’Daniel JM, Haga SB, Willard HF. Considerations for the impact of personal
\ngenome information: a study of genomic profiling among genetics and genomics
\nprofessionals. J Genet Couns. 2010 Aug;19(4):387-401. doi:
\n10.1007\/s10897-010-9297-x. Epub 2010 Mar 30. PubMed PMID: 20352309.<\/p>\n
205: Powell CM. What Genomic Sequencing Can Offer Universal Newborn Screening
\nPrograms. Hastings Cent Rep. 2018 Jul;48 Suppl 2:S18-S19. doi: 10.1002\/hast.878.
\nPubMed PMID: 30133725.<\/p>\n
206: Bailey DB Jr, Berry-Kravis E, Gane LW, Guarda S, Hagerman R, Powell CM,
\nTassone F, Wheeler A. Fragile X Newborn Screening: Lessons Learned From a
\nMultisite Screening Study. Pediatrics. 2017 Jun;139(Suppl 3):S216-S225. doi:
\n10.1542\/peds.2016-1159H. PubMed PMID: 28814542.<\/p>\n
207: Khan CM, Moore EG, Leos C, Rini C. Patient hopes for diagnostic genomic
\nsequencing: roles of uncertainty and social status. Eur J Hum Genet. 2016
\nJun;24(6):803-8. doi: 10.1038\/ejhg.2015.204. Epub 2015 Sep 23. PubMed PMID:
\n26395557; PubMed Central PMCID: PMC4867445.<\/p>\n
208: Gray SW, Martins Y, Feuerman LZ, Bernhardt BA, Biesecker BB, Christensen KD,
\nJoffe S, Rini C, Veenstra D, McGuire AL; CSER Consortium Outcomes and Measures
\nWorking Group. Social and behavioral research in genomic sequencing: approaches
\nfrom the Clinical Sequencing Exploratory Research Consortium Outcomes and
\nMeasures Working Group. Genet Med. 2014 Oct;16(10):727-35. doi:
\n10.1038\/gim.2014.26. Epub 2014 Mar 13. Review. PubMed PMID: 24625446; PubMed
\nCentral PMCID: PMC4163120.<\/p>\n
209: O’Neill SC, Rini C, Goldsmith RE, Valdimarsdottir H, Cohen LH, Schwartz MD.
\nDistress among women receiving uninformative BRCA1\/2 results: 12-month outcomes.
\nPsychooncology. 2009 Oct;18(10):1088-96. doi: 10.1002\/pon.1467. PubMed PMID:
\n19214961; PubMed Central PMCID: PMC3503506.<\/p>\n
210: Morrissey C, Walker RL. The Ethics of General Population Preventive Genomic
\nSequencing: Rights and Social Justice. J Med Philos. 2018 Jan 12;43(1):22-43.
\ndoi: 10.1093\/jmp\/jhx034. PubMed PMID: 29342286; PubMed Central PMCID: PMC5901094.<\/p>\n
211: Walker RL, Morrissey C. Bioethics methods in the ethical, legal, and social
\nimplications of the human genome project literature. Bioethics. 2014
\nNov;28(9):481-90. doi: 10.1111\/bioe.12023. Epub 2013 Jun 24. Review. PubMed PMID:
\n23796275; PubMed Central PMCID: PMC3785570.<\/p>\n
212: Morrissey C, Walker RL. Funding and Forums for ELSI Research: Who (or What)
\nis Setting the Agenda? AJOB Prim Res. 2012 Jan 1;3(3):51-60. Epub 2012 Jun 19.
\nPubMed PMID: 22888470; PubMed Central PMCID: PMC3413296.<\/p>\n
213: Walker RL, Morrissey C. Charting ELSI’s future course: lessons from the
\nrecent past. Genet Med. 2012 Feb;14(2):259-67. doi: 10.1038\/gim.2011.60. Epub
\n2012 Jan 19. PubMed PMID: 22261758; PubMed Central PMCID: PMC5901958.<\/p>\n
214: Lopes-J\u00fanior LC, Carvalho J\u00fanior PM, de Faria Ferraz VE, Nascimento LC, Van
\nRiper M, Fl\u00f3ria-Santos M. Genetic education, knowledge and experiences between
\nnurses and physicians in primary care in Brazil: A cross-sectional study. Nurs
\nHealth Sci. 2017 Mar;19(1):66-74. doi: 10.1111\/nhs.12304. Epub 2016 Aug 11.
\nPubMed PMID: 27510609.<\/p>\n
215: Dressler LG, Deal AM, Patel J, Markey J, Riper MV, McLeod HL. Cancer
\npharmacogenomics, adoption by oncologists and patient benefit. Per Med. 2014
\nMar;11(2):143-153. doi: 10.2217\/pme.14.1. PubMed PMID: 29751378.<\/p>\n
216: Prows CA, Hopkin RJ, Barnoy S, Van Riper M. An update of childhood genetic
\ndisorders. J Nurs Scholarsh. 2013 Mar;45(1):34-42. doi: 10.1111\/jnu.12003. Epub
\n2013 Jan 7. Review. PubMed PMID: 23294802.<\/p>\n
217: Choi H, Van Riper M, Thoyre S. Decision making following a prenatal
\ndiagnosis of Down syndrome: an integrative review. J Midwifery Womens Health.
\n2012 Mar-Apr;57(2):156-64. doi: 10.1111\/j.1542-2011.2011.00109.x. Epub 2012 Feb
\n3. Review. PubMed PMID: 22432488.<\/p>\n
218: Roederer MW, Van Riper M, Valgus J, Knafl G, McLeod H. Knowledge, attitudes
\nand education of pharmacists regarding pharmacogenetic testing. Per Med. 2012
\nJan;9(1):19-27. doi: 10.2217\/pme.11.87. PubMed PMID: 29783293.<\/p>\n
219: Dodson C, Van Riper M. Analysis of clinicians’ attitudes towards
\npharmacogenomics. Per Med. 2011 Sep;8(5):533-540. doi: 10.2217\/pme.11.43. PubMed
\nPMID: 29793249.<\/p>\n
220: Hsiao CY, Van Riper M, Lee SH, Chen SJ, Lin SC. Taiwanese nursing students’
\nperceived knowledge and clinical comfort with genetics. J Nurs Scholarsh. 2011
\nJun;43(2):125-32. doi: 10.1111\/j.1547-5069.2011.01389.x. Epub 2011 Apr 19. PubMed
\nPMID: 21605316.<\/p>\n
221: Cadigan RJ, Easter MM, Dobson AW, Davis AM, Rothschild BB, Zimmer C,
\nSterling R, Henderson G. “That’s a good question”: university researchers’ views
\non ownership and retention of human genetic specimens. Genet Med. 2011
\nJun;13(6):569-75. doi: 10.1097\/GIM.0b013e318211a9c2. PubMed PMID: 21659952;
\nPubMed Central PMCID: PMC3385643.<\/p>\n
222: Michie M, Henderson G, Garrett J, Corbie-Smith G. “If I could in a small way
\nhelp”: motivations for and beliefs about sample donation for genetic research. J
\nEmpir Res Hum Res Ethics. 2011 Jun;6(2):57-70. doi: 10.1525\/jer.2011.6.2.57.
\nPubMed PMID: 21680977; PubMed Central PMCID: PMC3313647.<\/p>\n
223: Corbie-Smith G, Blumenthal C, Henderson G, Garrett J, Bussey-Jones J,
\nMoloney M, Sandler RS, Lloyd SW, Dorrance J, Darter J. Studying genetic research
\nparticipants: lessons from the “Learning About Research in North Carolina” study.
\nCancer Epidemiol Biomarkers Prev. 2008 Aug;17(8):2019-24. doi:
\n10.1158\/1055-9965.EPI-07-2868. PubMed PMID: 18708393; PubMed Central PMCID:
\nPMC3037258.<\/p>\n
224: Henderson G, Garrett J, Bussey-Jones J, Moloney ME, Blumenthal C,
\nCorbie-Smith G. Great expectations: views of genetic research participants
\nregarding current and future genetic studies. Genet Med. 2008 Mar;10(3):193-200.
\ndoi: 10.1097\/GIM.0b013e318164e4f5. PubMed PMID: 18344709.<\/p>\n
225: Sterling R, Henderson GE, Corbie-Smith G. Public willingness to participate
\nin and public opinions about genetic variation research: a review of the
\nliterature. Am J Public Health. 2006 Nov;96(11):1971-8. Epub 2006 Oct 3. Review.
\nPubMed PMID: 17018829; PubMed Central PMCID: PMC1751820.<\/p>\n
226: Buchbinder M, Timmermans S. Newborn screening for metabolic disorders:
\nparental perceptions of the initial communication of results. Clin Pediatr
\n(Phila). 2012 Aug;51(8):739-44. doi: 10.1177\/0009922812446011. Epub 2012 May 4.
\nPubMed PMID: 22563060.<\/p>\n
227: Timmermans S, Buchbinder M. Expanded newborn screening: articulating the
\nontology of diseases with bridging work in the clinic. Sociol Health Illn. 2012
\nFeb;34(2):208-20. doi: 10.1111\/j.1467-9566.2011.01398.x. Epub 2011 Sep 19. PubMed
\nPMID: 21929648.<\/p>\n
228: Buchbinder M, Timmermans S. Newborn screening and maternal diagnosis:
\nrethinking family benefit. Soc Sci Med. 2011 Oct;73(7):1014-8. doi:
\n10.1016\/j.socscimed.2011.06.062. Epub 2011 Jul 27. PubMed PMID: 21835525.<\/p>\n
229: Buchbinder M, Timmermans S. Medical technologies and the dream of the
\nperfect newborn. Med Anthropol. 2011 Jan;30(1):56-80. doi:
\n10.1080\/01459740.2010.531065. PubMed PMID: 21218356.<\/p>\n
230: Timmermans S, Buchbinder M. Patients-in-waiting: Living between sickness and
\nhealth in the genomics era. J Health Soc Behav. 2010 Dec;51(4):408-23. doi:
\n10.1177\/0022146510386794. PubMed PMID: 21131618.<\/p>\n
231: Prince AE. Response to peer commentaries: prevention for those who can pay.
\nJ Law Biosci. 2016 Feb 6;3(1):202-205. eCollection 2016 Apr. PubMed PMID:
\n27774243; PubMed Central PMCID: PMC5033441.<\/p>\n
232: Prince AE. TANTAMOUNT TO FRAUD?: EXPLORING NON-DISCLOSURE OF GENETIC
\nINFORMATION IN LIFE INSURANCE APPLICATIONS AS GROUNDS FOR POLICY RESCISSION.
\nHealth Matrix Clevel. 2016;26:255-307. PubMed PMID: 27263254.<\/p>\n
233: Prince AE. Prevention for those who can pay: insurance reimbursement of
\ngenetic-based preventive interventions in the liminal state between health and
\ndisease. J Law Biosci. 2015 Jul 1;2(2):365-395. PubMed PMID: 26339500; PubMed
\nCentral PMCID: PMC4555880.<\/p>\n
234: Prince AE. Beyond social media: inadvertent acquisition of genetic
\ninformation in medical certifications. Am J Bioeth. 2014;14(11):48-50. doi:
\n10.1080\/15265161.2014.957624. PubMed PMID: 25325812.<\/p>\n
235: Prince AE, Berkman BE. When does an illness begin: genetic discrimination
\nand disease manifestation. J Law Med Ethics. 2012 Fall;40(3):655-64. doi:
\n10.1111\/j.1748-720X.2012.00696.x. PubMed PMID: 23061591; PubMed Central PMCID:
\nPMC4142506.<\/p>\n
236: Radford C, Prince A, Lewis K, Pal T. Factors which impact the delivery of
\ngenetic risk assessment services focused on inherited cancer genomics: expanding
\nthe role and reach of certified genetics professionals. J Genet Couns. 2014
\nAug;23(4):522-30. doi: 10.1007\/s10897-013-9668-1. Epub 2013 Dec 4. PubMed PMID:
\n24306140.<\/p>\n
237: Allyse M, Michie M. Not-so-incidental findings: the ACMG recommendations on
\nthe reporting of incidental findings in clinical whole genome and whole exome
\nsequencing. Trends Biotechnol. 2013 Aug;31(8):439-41. doi:
\n10.1016\/j.tibtech.2013.04.006. Epub 2013 May 9. PubMed PMID: 23664778; PubMed
\nCentral PMCID: PMC4086155.<\/p>\n
238: L\u00e1zaro-Mu\u00f1oz G. The fiduciary relationship model for managing clinical
\ngenomic “incidental” findings. J Law Med Ethics. 2014 Winter;42(4):576-89. doi:
\n10.1111\/jlme.12177. PubMed PMID: 25565622; PubMed Central PMCID: PMC4312667.<\/p>\n
239: Meagher KM, Lee LM. Integrating Public Health and Deliberative Public
\nBioethics: Lessons from the Human Genome Project Ethical, Legal, and Social
\nImplications Program. Public Health Rep. 2016 Jan-Feb;131(1):44-51. PubMed PMID:
\n26843669; PubMed Central PMCID: PMC4716471.<\/p>\n","protected":false},"excerpt":{"rendered":"